Depósito Digital de Documentos de la UAB Encontrados 2 registros  La búsqueda tardó 0.00 segundos. 
1.
11 p, 712.3 KB Comparison of covid-19 and non-covid-19 pneumonia in down syndrome / Real de Asua, Diego (Instituto de Investigación Hospital Universitario de la Princesa) ; Mayer, Miguel Angel (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Del Carmen Ortega, María (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Borrel, Jose M. (Down España Huesca) ; de Jesús Bermejo, Teresa (Unidad de Neuropediatría. Instituto Hispalense de Pediatría) ; González-lamuño, Domingo (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ; Manso, Coral (Down España) ; Moldenhauer, Fernando (Instituto de Investigación Hospital Universitario de la Princesa) ; Carmona Iragui, María (Institut d'Investigació Biomèdica Sant Pau) ; Hüls, Anke (Department of Epidemiology and Gangarosa. Department of Environmental Health. Rollins School of Public Health. Emory University) ; Sherman, Stephanie L. (Department of Human Genetics. School of Medicine. Emory University) ; Strydom, Andre (The London Down Syndrome (LonDownS) Consortium. London. United Kingdom and South London and the Maudsley NHS Foundation Trust) ; De La Torre, Rafael (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ; Dierssen, Mara (Biomedical Research Networking Center for Rare Diseases (CIBERER)) ; Universitat Autònoma de Barcelona
Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. [...]
2021 - 10.3390/jcm10163748
Journal of clinical medicine, Vol. 10 Núm. 16 (february 2021) , p. 3748  
2.
13 p, 1.5 MB Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey / Hüls, Anke (Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA) ; Costa, Alberto C. S. (Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA) ; Dierssen, Mara (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Baksh, R. Asaad (The London Down Syndrome (LonDownS) Consortium, London, United Kingdom) ; Bargagna, Stefania (Fondazione Stella Maris IRCCS, Pisa, Italy) ; Baumer, Nicole (Harvard Medical School) ; Brandão, Ana Claudia (Hospital Israelita Albert Einstein (Sao Paolo, Brasil)) ; Carfi, Angelo (Policlinico Universitario Agostino Gemelli IRCCS (Roma, Itàlia)) ; Carmona Iragui, María (Institut d'Investigació Biomèdica Sant Pau) ; Chicoine, Brian (Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA) ; Ghosh, Sujay (Cytogenetics and Genomics Reserach Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India) ; Lakhanpaul, Monica (Whttington NHS Trust, London, United Kingdom; Down Syndrome Medical Interest Group, London, United Kingdom) ; Manso, Coral (CM: DOWN ESPAÑA, Madrid, Spain) ; Mayer, Miguel-Angel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ortega, Maria del Carmen (Hospital Universitario 12 de Octubre (Madrid)) ; de Asua, Diego Real (Instituto de Investigación Hospital Universitario de la Princesa) ; Rebillat, Anne-Sophie (Institut Jérôme Lejeune, Paris, France) ; Russell, Lauren Ashley (Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA) ; Sgandurra, Giuseppina (Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy) ; Valentini, Diletta (Bambino Gesù Children's Hospital) ; Sherman, Stephanie L. (Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA) ; Strydom, Andre (South London and the Maudsley NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. The T21RS COVID-19 Initiative launched an international survey for clinicians or caregivers on patients with COVID-19 and DS. [...]
2021 - 10.1016/j.eclinm.2021.100769
EClinicalMedicine, february 2021  

Vea también: autores con nombres similares
2 Mayer, M.
1 Mayer, M. A.
2 Mayer, Marc , 1947-
42 Mayer, Marc,
1 Mayer, Mathias
1 Mayer, Michela
1 Mayer, Miguel Angel
1 Mayer, Miquel Àngel
1 Mayer, Monika
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.